AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Hepatitis C Epidemic and Barriers to Testing among MSM with High Risk Behaviors in China: A GSN-delivered Cross-sectional StudyView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Validation of a novel point-of-care ALT test to determine treatment eligibility in hepatitis B patients: a pilot cohort studyView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020A novel point -of- care test (POC) for diagnosis of hepatitis Core antigenView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Frequency of Occult Hepatitis B Virus among blood Donors in Khartoum State, Sudan: a preliminary study.View Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Reducing Read Time of Point of Care Test Preserves Detection of Hepatitis C Virus and Reduces Need for Reflex RNAView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020The Effect of COVID-19 on the Hepatitis C Screening in GeorgiaView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Sustained reduction in prevalence of Hepatitis C viremina in the prison setting after 3rd year of TraPHepC (Treatment as prevention for hepatitis C) program in IcelandView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Strategies for population-based screening and treatment of hepatitis B in sub-Saharan Africa: a mathematical modelling study in The GambiaView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Concordance between FibroScan® and Aspartate aminotransferase-to-Platelet Ratio Index (APRI) using different cut-off values in 301 Asian adults with chronic HCV with no or compensated cirrhosis in Thailand and MalaysiaView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020A Model for Collaborative Care to Increase Testing and Treatment of HCV in a Shelter Population During COVID-19View Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Risks factors associated with HIV and hepatitis C virus co-infection among people who inject drugs in CambodiaView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020A Novel Approach Continuum from Identification to Elimination in HCV-Infected Individuals on Opioid Substitution Therapy and High-Risk PopulationsView Abstract